(Q36180905)

12 August 2017

title

The allopurinol hypersensitivity syndrome. (English)

1 reference

12 August 2017

1 reference

Lupton GP

1

1 reference

12 August 2017

Odom RB

series ordinal

2

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 October 1979

1 reference

Journal of the American Academy of Dermatology

12 August 2017

published in

1 reference

12 August 2017

volume

1

1 reference

12 August 2017

issue

4

1 reference

12 August 2017

page(s)

365-374

1 reference

Allopurinol in the Treatment of Gout

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2879%2970031-4

7 January 2021

Alopecia and ichthyosis secondary to allopurinol

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2879%2970031-4

7 January 2021

Possible association between macular lesions and allopurinol

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2879%2970031-4

7 January 2021

Acute cholangitis after allopurinol treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2879%2970031-4

7 January 2021

Allopurinol-induced interstitial nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2879%2970031-4

7 January 2021

Drug Induced Interstitial Nephritis, Hepatitis and Exfoliative Dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2879%2970031-4

7 January 2021

Allopurinol-associated arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2879%2970031-4

7 January 2021

Urinary Xanthine Stones-a Rare Complication of Allopurinol Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2879%2970031-4

7 January 2021

Allopurinol-induced arteritis in partial HGPRTase deficiency. Atypical seizure manifestation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2879%2970031-4

7 January 2021

Aplastic agranulocytosis after allopurinol therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2879%2970031-4

7 January 2021

Massive Hepatic Necrosis in a Patient Receiving Allopurinol

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2879%2970031-4

7 January 2021

Vasculitis with allopurinol therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2879%2970031-4

7 January 2021

Toxic Epidermal Necrolysis Associated With Allopurinol Administration

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2879%2970031-4

7 January 2021

Severe allopurinol hypersensitivity. Association with thiazides and prior renal compromise

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2879%2970031-4

7 January 2021

Allergic Reaction to Allopurinol with Cross-Reactivity to Oxypurinol

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2879%2970031-4

7 January 2021

Allopurinol Associated Hypersensitivity Reactions: Cutaneous and Renal Manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2879%2970031-4

7 January 2021

Excess of ampicillin rashes associated with allopurinol or hyperuricemia. A report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2879%2970031-4

7 January 2021

Impairment of drug metabolism in man by allopurinol and nortriptyline

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2879%2970031-4

7 January 2021

Metabolic studies of allopurinol, an inhibitor of xanthine oxidase

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2879%2970031-4

7 January 2021

Renal clearance of oxipurinol, the chief metabolite of allopurinol

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2879%2970031-4

7 January 2021

Systemic "allergic" vasculitis. Clinical and pathological relationships

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2879%2970031-4

7 January 2021

Depletion of erythrocyte phosphoribosylpyrophosphate in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2879%2970031-4

7 January 2021

Uric acid retention due to hydrochlorothiazide

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2879%2970031-4

7 January 2021

Allopurinol hypersensitivity. Granular deposition of IgM at the dermal-epidermal junction

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2879%2970031-4

7 January 2021

Desensitisation in a patient with chronic renal disease and severe allergy to allopurinol

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2879%2970031-4

7 January 2021

Further experiences of toxic epidermal necrolysis incriminating allopurinol, pyrazolone and derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2879%2970031-4

7 January 2021

10.1016/S0190-9622(79)70031-4

Identifiers

DOI

1 reference

release_klqyya77i5ab7gieo77hrfpqtu

12 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/klqyya77i5ab7gieo77hrfpqtu

24 November 2022

mapped directly with Wikidata item

1 reference